Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons dr. A.L. Messchendorp

Publicaties

Class switching toward IgG4 six months after primary mRNA-based COVID-19 vaccination in kidney patients

COVID-19 boosters restore virus-specific immune responses in kidney transplant recipients unresponsive to primary vaccination

Effects of the GnRH agonist leuprorelin on liver volume in premenopausal women with severe polycystic liver disease

Kidney Transplant Recipients Develop Nasal Mucosal Antibodies to SARS-CoV-2 With ACE2-Inhibiting Activity Following mRNA Vaccination

Renal blood flow as marker for disease progression in autosomal dominant polycystic kidney disease

Unveiling Donor-Derived BKPyV DNAemia Through Analysis of Contralateral Kidney Transplant Recipients

Replacing Mycophenolate Mofetil by Everolimus in Kidney Transplant Recipients to Increase Vaccine Immunogenicity: Results of a Randomized Controlled Trial

The phenotype and functionality of spike-specific CD4+ T cells after COVID-19 vaccination associates with time after transplantation in transplant recipients

Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant Recipients

Patient engagement as a collaborative process in a large Dutch COVID-19 vaccination study (RECOVAC) - insight into the contribution of patient engagement and learnings for the future

Pers/media

Vaccinatieonderzoek samen met kwetsbare groepen

Immunosuppressive Drugs for Organ Transplant Increase COVID-19 Hospitalization Risk

Immunosuppressive Drugs for Organ Transplant Up COVID-19 Hospitalization Risk

The REnal Patients COVID-19 VACcination Immune Response (RECOVAC IR) Study (RECOVAC-IR)

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijn

Meer informatie over de Sustainable Development Goals.